or Try an Advanced Search...

    Technical Analysis for NRXP - NeuroRx, Inc.

    Grade Last Price % Change Price Change
    F 1.21 -1.22% -0.02
    NRXP closed down 1.22 percent on Wednesday, November 20, 2024, on 51 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical NRXP trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Fell Below 20 DMA Bearish -1.22%
    Lower Bollinger Band Touch Weakness -1.22%
    Crossed Above 20 DMA Bullish -6.92%
    Pocket Pivot Bullish Swing Setup -6.92%
    Spinning Top Other -6.92%
    Volume Surge Other -6.92%
    Gapped Up Strength -6.92%
    Older End-of-Day Signals for NRXP ...

       Recent Intraday Alerts

    Alert Time
    Down 2 % about 20 hours ago
    Down 1% about 20 hours ago
    60 Minute Opening Range Breakdown 2 days ago
    3x Volume Pace 2 days ago
    Down 5% 2 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    NRXP Chart by TradingView
    Basic chart:

    Profile

    NeuroRx, Inc. operates as a clinical stage-small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders. Its drug candidate includes Cyclurad, an oral therapeutic for the treatment of acute/elevated suicidal ideation/crisis in bipolar depression. The company was incorporated in 2015 and is headquartered in Wilmington, Delaware.
    Classification
    Sector: Industrials
    Industry: Conglomerates
    Keywords: Life Sciences Health Sciences Health Care Central Nervous System Disorders Antidepressants Bipolar Disorder Treatment Of Central Nervous System Disorders Atypical Antipsychotics Bipolar Depression

    Is NRXP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 NRx Pharmaceuticals reports Q3 results
    Nov 14 NRx Pharmaceuticals (NASDAQ:NRXP) Reports Third Quarter and Year to Date 2024 Financial Results and Provides Business Update
    Nov 14 NRx Pharmaceuticals files to sell 3.3M shares of common stock for holders
    Nov 13 NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Conference Call to Discuss Third Quarter and Year to Date 2024 Financial Results to November 18, 2024
    Oct 31 NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule
    Oct 30 HOPE Therapeutics and NRx Pharmaceuticals to buy Florida Interventional Psychiatry Clinics
    Oct 30 HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire its First Florida Interventional Psychiatry Clinics
    Oct 23 NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024
    Oct 21 NRx started at buy by EF Hutton, cites suicide prevention focus
    Oct 12 NRx Pharmaceuticals Leadership Shift and Strategic Governance Decisions
    See more NRXP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.333
    52 Week Low 1.1
    Average Volume 136,209
    200-Day Moving Average 2.89
    50-Day Moving Average 1.42
    20-Day Moving Average 1.28
    10-Day Moving Average 1.25
    Average True Range 0.10
    RSI (14) 41.86
    ADX 19.33
    +DI 18.97
    -DI 20.93
    Chandelier Exit (Long, 3 ATRs) 1.14
    Chandelier Exit (Short, 3 ATRs) 1.43
    Upper Bollinger Bands 1.41
    Lower Bollinger Band 1.14
    Percent B (%b) 0.25
    BandWidth 20.76
    MACD Line -0.05
    MACD Signal Line -0.06
    MACD Histogram 0.0045
    Fundamentals Value
    Market Cap 103.05 Million
    Num Shares 85.2 Million
    EPS -0.50
    Price-to-Earnings (P/E) Ratio -2.42
    Price-to-Sales 0.00
    Price-to-Book 6.95
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.27
    Resistance 3 (R3) 1.27 1.26 1.26
    Resistance 2 (R2) 1.26 1.24 1.26 1.26
    Resistance 1 (R1) 1.23 1.23 1.23 1.23 1.25
    Pivot Point 1.22 1.22 1.21 1.22 1.22
    Support 1 (S1) 1.19 1.20 1.19 1.19 1.17
    Support 2 (S2) 1.18 1.19 1.18 1.16
    Support 3 (S3) 1.15 1.18 1.16
    Support 4 (S4) 1.15